HIV-associated lymphoma: promising new results, but with toxicity

被引:12
作者
Straus, DJ [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Bronx, NY USA
关键词
D O I
10.1182/blood-2004-12-4729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment of HIV-associated non-Hodgkin lymphoma with rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide resulted in high complete remission and 2-year failure-free and overall survival rates but a high rate of infection.
引用
收藏
页码:1842 / 1842
页数:1
相关论文
共 5 条
[1]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[2]   Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection [J].
Kaplan, LD ;
Straus, DJ ;
Testa, MA ;
VonRoenn, J ;
Dezube, BJ ;
Cooley, TP ;
Herndier, B ;
Northfelt, DW ;
Huang, J ;
Tulpule, A ;
Levine, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (23) :1641-1648
[3]  
KAPLAN LD, 2003, P AN M AM SOC CLIN, V22, P564
[4]   Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology [J].
Little, RF ;
Pittaluga, S ;
Grant, N ;
Steinberg, SM ;
Kavlick, MF ;
Mitsuya, H ;
Franchini, G ;
Gutierrez, M ;
Raffeld, M ;
Jaffe, ES ;
Shearer, G ;
Yarchoan, R ;
Wilson, WH .
BLOOD, 2003, 101 (12) :4653-4659
[5]   Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493) [J].
Sparano, JA ;
Weller, E ;
Nazeer, T ;
Habermann, T ;
Traynor, AE ;
Manalo, J ;
Cassileth, P .
BLOOD, 2002, 100 (05) :1634-1640